EUVIMEDEUVIMED entdecken
Crossref

Vaginal Misoprostol Pharmacokinetic Changes in Obese Parturient Women Who Presented Labor Induction Failure

Gabriela Campos de Oliveira Filgueira, Jhohann Richard de Lima Benzi iD, Grazielle de Fátima Pinto Rodrigues iD, Maria Paula Marques, Matheus De Lucca Thomaz, Geraldo Duarte, Vera Lucia Lanchote iD, Ricardo Carvalho Cavalli

The Journal of Clinical Pharmacology · 2025

DOI: 10.1002/jcph.6166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Gabriela Campos de Oliveira Filgueira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Hauptthemen laut MEDLINE: Misoprostol, Labor, Induced, Obesity, Oxytocics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical experience shows an increased duration of labor in obese parturient women. It is unclear if this population should receive the same dose of vaginal misoprostol for induction of labor as non‐obese parturient women. We investigate the influence of obesity on the pharmacokinetics and placental transfer of the metabolite misoprostol acid in parturient women. Parturient women (n = 40) were enrolled and received misoprostol 25 µg/6 h vaginally and were allocated into two groups according to the pre‐pregnancy body mass index (BMI 30 kg/m 2 obese, n = 22) or according to the labor induction outcome (failure [n = 10] or success [n = 30]). Blood collection for pharmacokinetic study occurred after the first misoprostol dose. The pharmacokinetic parameters obtained in non‐obese parturient women were not statistically different from those obtained in obese group ( P Value > .05). However, when the parturient women were grouped by the labor induction outcome, the failed labor induction group presented a higher (median [interquartile range]) BMI (44.4 [34.6‐47.9] vs 33.7 [28.9‐36.5] kg/m 2 ) ( P Value = .0017), lower C max (11.5 [4.82‐22.2] vs 22.8 [14.2‐30.8] pg/mL) ( P Value = .0308) and not statistically different AUC 0‐6 (31.8 [13.4‐61.5] vs 53.4 [35.4‐77.7]) pg•h/mL) ( P Value = .0580) and t max (2.50 [1.19‐4.25] vs 3.00 (1.88‐5.00) h ( P Value = .3198) when compared with parturient women who presented successful labor induction. This data suggests a higher loading dose (higher volume of distribution) and unchanged maintenance dose (unchanged AUC 0‐6 ) of misoprostol for this population. Further studies are required to investigate the efficacy and safety of higher misoprostol loading doses for this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolLabor, InducedObesityOxytocicsHumansFemalePregnancyAdultAdministration, IntravaginalBody Mass IndexYoung AdultTreatment Failure

Stichwörter der Autor:innen

labor inductionmisoprostolobesitypharmacokineticsplacental transferpregnancy

Substanzen

MisoprostolOxytocics

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
  • Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
  • Department of Clinical Analysis, Food Science and Toxicology, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

ORCID-Profile: Jhohann Richard de Lima Benzi, Grazielle de Fátima Pinto Rodrigues, Vera Lucia Lanchote

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Filgueira, G. C. O., Benzi, J. R. L., Rodrigues, G. F. P., Marques, M. P., Thomaz, M. L., Duarte, G., Lanchote, V. L., & Cavalli, R. C. (2025). Vaginal Misoprostol Pharmacokinetic Changes in Obese Parturient Women Who Presented Labor Induction Failure. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.6166

Vancouver

Filgueira GCO, Benzi JRL, Rodrigues GFP, Marques MP, Thomaz ML, Duarte G, et al. Vaginal Misoprostol Pharmacokinetic Changes in Obese Parturient Women Who Presented Labor Induction Failure. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.6166

BibTeX
@article{Filgueira2025,
  author = {Filgueira, Gabriela Campos de Oliveira and Benzi, Jhohann Richard de Lima and Rodrigues, Grazielle de Fátima Pinto and Marques, Maria Paula and Thomaz, Matheus De Lucca and Duarte, Geraldo and Lanchote, Vera Lucia and Cavalli, Ricardo Carvalho},
  title = {Vaginal Misoprostol Pharmacokinetic Changes in Obese Parturient Women Who Presented Labor Induction Failure},
  journal = {The Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/jcph.6166}
}
Kostenlos starten →